Creative Medical Technology Holdings Inc
CELZ2.824USD
-0.046-1.61%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
7.29MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Creative Medical Technology Holdings Inc Unternehmen
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company dedicated to the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. The Company conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.
Creative Medical Technology Holdings Inc Informationen
BörsenkürzelCELZ
Name des UnternehmensCreative Medical Technology Holdings Inc
IPO-datumMay 01, 2009
CEOMr. Timothy Warbington
Anzahl der mitarbeiter4
WertpapierartOrdinary Share
GeschäftsjahresendeMay 01
Addresse211 E. Osborn Rd.
StadtPHOENIX
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl85012
Telefon14803992822
Websitehttps://creativemedicaltechnology.com/
BörsenkürzelCELZ
IPO-datumMay 01, 2009
CEOMr. Timothy Warbington
Führungskräfte von Creative Medical Technology Holdings Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Timothy Warbington
Mr. Timothy Warbington
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
12.21K
--
Mr. Donald Dickerson
Mr. Donald Dickerson
Chief Financial Officer, Senior Vice President, Director
Chief Financial Officer, Senior Vice President, Director
17.00
--
Mr. Michael H. Finger
Mr. Michael H. Finger
Independent Director
Independent Director
--
--
Mr. Bruce S. Urdang, Esq.
Mr. Bruce S. Urdang, Esq.
Independent Director
Independent Director
--
--
Ms. Susan Hegarty Snow
Ms. Susan Hegarty Snow
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Timothy Warbington
Mr. Timothy Warbington
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
12.21K
--
Mr. Donald Dickerson
Mr. Donald Dickerson
Chief Financial Officer, Senior Vice President, Director
Chief Financial Officer, Senior Vice President, Director
17.00
--
Mr. Michael H. Finger
Mr. Michael H. Finger
Independent Director
Independent Director
--
--
Mr. Bruce S. Urdang, Esq.
Mr. Bruce S. Urdang, Esq.
Independent Director
Independent Director
--
--
Ms. Susan Hegarty Snow
Ms. Susan Hegarty Snow
Independent Director
Independent Director
--
--
Umsatzaufteilung
Keine Daten
Keine Daten
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Sat, Sep 6
Aktualisiert: Sat, Sep 6
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Creative Medical Health, Inc.
0.88%
Geode Capital Management, L.L.C.
0.81%
The Vanguard Group, Inc.
0.68%
Warbington (Timothy)
0.47%
Citadel Advisors LLC
0.43%
Andere
96.72%
Aktionäre
Aktionäre
Anteil
Creative Medical Health, Inc.
0.88%
Geode Capital Management, L.L.C.
0.81%
The Vanguard Group, Inc.
0.68%
Warbington (Timothy)
0.47%
Citadel Advisors LLC
0.43%
Andere
96.72%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
1.43%
Corporation
0.88%
Investment Advisor/Hedge Fund
0.88%
Individual Investor
0.49%
Hedge Fund
0.47%
Andere
95.85%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
25
71.80K
2.78%
-205.37K
2025Q2
25
242.47K
9.38%
+92.22K
2025Q1
27
239.16K
9.28%
+93.67K
2024Q4
29
67.44K
3.86%
-172.00K
2024Q3
32
114.73K
8.54%
-150.07K
2024Q2
34
115.50K
8.55%
-269.83K
2024Q1
36
151.46K
11.09%
-154.43K
2023Q4
38
64.97K
4.67%
-273.04K
2023Q3
42
127.49K
15.08%
-223.19K
2023Q2
41
127.02K
15.07%
-210.98K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Creative Medical Health, Inc.
22.70K
0.88%
--
--
Apr 15, 2025
Geode Capital Management, L.L.C.
20.88K
0.81%
+2.61K
+14.28%
Jun 30, 2025
The Vanguard Group, Inc.
17.63K
0.68%
--
--
Jun 30, 2025
Warbington (Timothy)
12.21K
0.47%
--
--
Apr 15, 2025
Citadel Advisors LLC
11.14K
0.43%
+11.14K
--
Jun 30, 2025
Northern Trust Global Investments
10.00K
0.39%
+10.00K
--
Jun 30, 2025
Allworth Financial, L.P.
4.00K
0.15%
+4.00K
--
Jun 30, 2025
Ameritas Advisory Services, LLC
2.28K
0.09%
+2.28K
--
Jun 30, 2025
Bridgeway Capital Management, LLC
1.85K
0.07%
+1.85K
--
Jun 30, 2025
Northern Trust Investments, Inc.
1.71K
0.07%
+1.71K
--
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Name
Anteil
Keine Daten
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
Datum
Art
Verhältnis
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
